Advancements in Viral Hepatitis From EASL 2022
Jul 05, 2022•7 min•Ep. 180
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
In this episode, Nancy Reau, MD, discusses new viral hepatitis data from EASL 2022, including:
- Novel therapeutics for HBV
- Therapeutic vaccination for HBV
- Emerging treatment options for HDV
- HCV care cascade
- HCC monitoring after HCV cure
Presenter:
Nancy Reau, MD
Professor of Medicine
Chief, Section of Hepatology
Associate Director, Solid Organ Transplantation
Richard B. Capps Chair of Hepatology
Rush University Medical Center
Chicago, Illinois
Follow along with the downloadable slideset at:
https://bit.ly/3yJAruD
Link to full program:
https://bit.ly/3IeUapm
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
For the best experience, listen in Metacast app for iOS or Android